Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile
Sean Khozin, MD, MPH

@seankhozin

Physician-scientist, oncologist, building solutions at the intersection of biology, technology, and AI. Opinions my own

ID: 23780640

linkhttp://www.seankhozin.com calendar_today11-03-2009 15:48:06

4,4K Tweet

2,2K Followers

809 Following

Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

With more than 67 radioligand therapies (RLTs) in clinical trials targeting over 25 molecular markers across 20+ tumor types (and with two already approved agents; Lutathera and Pluvicto), capturing meaningful clinical ground, the latter generating $1.4 billion in revenue in

With more than 67 radioligand therapies (RLTs) in clinical trials targeting over 25 molecular markers across 20+ tumor types (and with two already approved agents; Lutathera and Pluvicto), capturing meaningful clinical ground, the latter generating $1.4 billion in revenue in
Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

AI + Physics for drug discovery: Interesting research on the challenging problem of predicting molecular photostability, a puzzle that has long eluded a definitive solution. Its ingenuity is in the "closed-loop transfer" (CLT) methodology, which elegantly weds AI-guided

AI + Physics for drug discovery:

Interesting research on the challenging problem of predicting molecular photostability, a puzzle that has long eluded a definitive solution. Its ingenuity is in the "closed-loop transfer" (CLT) methodology, which elegantly weds AI-guided
Gazelle غزاله شارمهد (@gazellesharmahd) 's Twitter Profile Photo

🚨 You don’t “stand with the Iranian people” if you’re still begging their executioners for a nuclear deal. Read that again. World leaders say one thing—then run into backroom talks with the regime murdering our children. That’s not diplomacy. That’s BETRAYAL. The ONLY message

Reza Pahlavi (@pahlavireza) 's Twitter Profile Photo

My fellow compatriots, We are now moving to the final phase of our struggle. It will be hard. But the regime is weak. It is near collapse. Only we, the Iranian people, can end it. To the military—as you’re given orders to lash out at the people—stand down. This is your final

Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

In the latest issue of NEJM, National Academy of Medicine rearticulates its enduring vision for a learning health system, one in which data, innovation, and continuous feedback loops drive better outcomes, deeper collaboration, and more patient-centered care. Grounded in a thoughtful set of

In the latest issue of <a href="/NEJM/">NEJM</a>, <a href="/theNAMedicine/">National Academy of Medicine</a> rearticulates its enduring vision for a learning health system, one in which data, innovation, and continuous feedback loops drive better outcomes, deeper collaboration, and more patient-centered care. Grounded in a thoughtful set of
Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

Is the tipping point near? Amazon is close to having as many robots as humans in its warehouses, with over one million robots currently deployed. About 75% of Amazon’s global deliveries are assisted by robotics and automation has led to fewer employees per facility and more

Shaun Maguire (@shaunmmaguire) 's Twitter Profile Photo

Reminder, this is an *INFO WAR* This account Iran Military News was one of the most influential accounts the last few weeks supporting Iran They accidentally posted this, meaning they probably forgot to switch accounts Meaning the account was likely part of a bot farm

Reminder, this is an *INFO WAR*

This account <a href="/TheIranMilitary/">Iran Military News</a> was one of the most influential accounts the last few weeks supporting Iran

They accidentally posted this, meaning they probably forgot to switch accounts

Meaning the account was likely part of a bot farm
Joe Lonsdale (@jtlonsdale) 's Twitter Profile Photo

1/ China is racing to dominate the future of medicine. We’re bogged down in bureaucracy. That’s why friends and I are donating to launch a “special forces” team of elite engineers inside the FDA -- modeled after how the DoD drives innovation. It’s time to move faster on cures!

Mark Dubowitz (@mdubowitz) 's Twitter Profile Photo

Your reminder: the Islamic Revolutionary Guard Corps doesn’t have “Iran” in its name. Khamenei and the IRGC are illegally occupying Iran.

Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

In my journey across medicine, regulation, and AI research, I've discovered that what institutions call "distinct disciplines" are actually the same mathematical operations—probabilistic inference, causal reasoning, decision-making under constraints—performed within different

In my journey across medicine, regulation, and AI research, I've discovered that what institutions call "distinct disciplines" are actually the same mathematical operations—probabilistic inference, causal reasoning, decision-making under constraints—performed within different
Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

The end of the post–World War II world order is not, in itself, surprising. What’s surprising is the widespread disbelief that such an order could ever unravel. For most of history, international systems have been unstable, multipolar, and subject to frequent upheaval. The real

The end of the post–World War II world order is not, in itself, surprising. What’s surprising is the widespread disbelief that such an order could ever unravel.

For most of history, international systems have been unstable, multipolar, and subject to frequent upheaval. The real
Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

An insightful nature article discusses how multipolarity, misinformation, and the integration of AI into military decision-making are shaping a new nuclear era. While the article acknowledges the growing complexity of global nuclear dynamics, it overlooks an important point: not

Sean Khozin, MD, MPH (@seankhozin) 's Twitter Profile Photo

The FDA’s rejection of Replimune’s RP1, a genetically engineered oncolytic virus that showed a 32.9% response rate in treatment-resistant melanoma, illustrates the complex challenges at the leading edge of drug development. The denial was not due to safety issues or lack of

The FDA’s rejection of Replimune’s RP1, a genetically engineered oncolytic virus that showed a 32.9% response rate in treatment-resistant melanoma, illustrates the complex challenges at the leading edge of drug development. The denial was not due to safety issues or lack of
Reza Pahlavi (@pahlavireza) 's Twitter Profile Photo

Together with Iranians of every background, belief, and experience, I have come to Munich to ignite a new chapter for our beloved Iran. United by the urgency of this moment and bound by shared principles, we will chart a new path forward as one nation ready to save our homeland